CryoPort (CYRX) Stock Price, News & Analysis

Company Overview

CryoPort, Inc. is a life sciences logistics company that provides temperature-controlled supply chain solutions for the development, manufacture and delivery of advanced therapies, biologics and other temperature-sensitive materials. Its services are used in areas including cell and gene therapy, regenerative medicine, pharmaceuticals, clinical research and reproductive medicine.

The company offers specialized shipping systems, cryogenic storage and monitoring technologies, logistics coordination, inventory management and related support services. Its solutions are designed to maintain the required temperature and handling conditions for biological materials throughout transportation and storage, from collection and manufacturing sites to clinical locations and treatment centers.

CryoPort serves customers internationally through a network of facilities, logistics providers and operating companies. Its portfolio has expanded through acquisitions and includes businesses involved in cryogenic equipment, biostorage, cell and gene therapy logistics, and temperature-monitoring technologies. The company is headquartered in Nashville, Tennessee, and its common stock trades on the Nasdaq under the symbol CYRX.

Key Stats

• Today's Range: $17.30 to $18.24
• 50-Day Range: $14.71 to $18.14
• 52-Week Range: $7.61 to $18.24
• Volume: 1.05 million shs
• Average Volume: 635,806 shs
• Market Capitalization: $918.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.38
• Consensus Rating: Moderate Buy

CryoPort Stock Analysis - MarketRank™

CryoPort scored higher than 29% of companies evaluated by MarketBeat, and ranked 723rd out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CryoPort has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for CryoPort is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

CryoPort has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for CryoPort are expected to grow in the coming year, from ($0.83) to ($0.78) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CryoPort is -20.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of CryoPort is -20.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

CryoPort has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.08% of the float of CryoPort has been sold short.

Short Interest Ratio / Days to Cover

CryoPort has a short interest ratio ("days to cover") of 5.83.

Change versus previous month

Short interest in CryoPort has recently increased by 2.68%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CryoPort does not currently pay a dividend.

Dividend Growth

CryoPort does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: N/A

News Sentiment

CryoPort has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for CryoPort this week, compared to 3 articles on an average week.

MarketBeat Follows

1 people have added CryoPort to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CryoPort insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $429,408.00 in company stock.

Percentage Held by Insiders

9.50% of the stock of CryoPort is held by insiders.

Percentage Held by Institutions

92.90% of the stock of CryoPort is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:CYRX
• CIK: 1124524
• Web: www.cryoportinc.com
• Phone: (949) 470-2300
• Fax: 949-470-2306
• Employees: 738
• Year Founded: 1999

Price Target and Rating

• Average Price Target for CryoPort: $18.38
• High Price Target: $25.00
• Low Price Target: $12.50
• Potential Upside/Downside: +1.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.90)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $78.30 million
• Net Margins: -20.05%
• Pretax Margin: -16.63%
• Return on Equity: -7.20%
• Return on Assets: -4.30%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.08
• Quick Ratio: 1.98

Sales & Book Value

• Annual Sales: $176.18 million
• Price / Sales: 5.22
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.19 per share
• Price / Book: 1.97

Miscellaneous

• Outstanding Shares: 50,650,000
• Free Float: 45,837,000
• Market Cap: $918.79 million
• Optionable: Optionable
• Beta: 1.96